Akebia Therapeutics
IPOPublic · Cambridge, United States · Founded 2007 · $63.0M raised
- Headquarters
- Cambridge, Massachusetts
- Employees
- 201–500
- Founded
- 2007
- Business Model
- B2B
- Website
- akebia.com
- Total Funding
- $63.0M
- Last Round
- $41.0M Series CJun 2013
- Rounds
- 3
- Type
- Public
About
Fully integrated renal biopharmaceutical company developing medicines for kidney disease patients.
Summary
Akebia Therapeutics is a Biotech company based in Cambridge, United States, founded in 2007. It has raised $63.0M in total across 3 rounds, most recently a $41.0M Series C round in Jun 2013. Investors include Venture Investors, Novartis Venture Fund and BlackRock.
Tech & App Stack
4 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2025
Sign up to see all 5 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...